Omgevingstrends en SWOT-analyse Utrecht 2016 von Schutjens, V.A.J.M, Speijer, Finn, van Hastenberg, Hans, van der Geijn, Bert, Straeter, Tom, van de Burgwal, Ben, Bergmeijer, Maarten, Oevering, Frits, Roso, Monique

Volltext bestellen

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI von Claassens, Daniel M.F, Vos, Gerrit J.A, Bergmeijer, Thomas O, Hermanides, Renicus S, van ’t Hof, Arnoud W.J, van der Harst, Pim, Barbato, Emanuele, Morisco, Carmine, Tjon Joe Gin, Richard M, Asselbergs, Folkert W, Mosterd, Arend, Herrman, Jean-Paul R, Dewilde, Willem J.M, Janssen, Paul W.A, Kelder, Johannes C, Postma, Maarten J, de Boer, Anthonius, Boersma, Cornelis, Deneer, Vera H.M, ten Berg, Jurriën M

Volltext

CYP2C19 genotype–guided antiplatelet therapy in ST-segment elevation myocardial infarction patients—Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics... von Bergmeijer, Thomas O., MD, Janssen, Paul W.A., MD, Schipper, Jurjan C., MD, Qaderdan, Khalid, MD, Ishak, Maycel, MD, Ruitenbeek, Rianne S., BSc, Asselbergs, Folkert W., MD, PhD, FESC, van ‘t Hof, Arnoud W.J., MD, PhD, Dewilde, Willem J.M., MD, Spanó, Fabrizio, MD, Herrman, Jean-Paul R., MD, PhD, Kelder, Johannes C., MD, PhD, Postma, Maarten J., PharmD, PhD, de Boer, Anthonius, MD, PhD, Deneer, Vera H.M., PharmD, PhD, ten Berg, Jurriën M., MD, PhD, FESC, FACC

Volltext

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial von Claassens, Daniel M. F., van Dorst, Pim W. M., Vos, Gerrit J. A., Bergmeijer, Thomas O., Hermanides, Renicus S., van ’t Hof, Arnoud W. J., van der Harst, Pim, Barbato, Emanuele, Morisco, Carmine, Tjon Joe Gin, Richard M., Asselbergs, Folkert W., Mosterd, Arend, Herrman, Jean-Paul R., Dewilde, Willem J. M., Postma, Maarten J., Deneer, Vera H. M., ten Berg, Jurriën M., Boersma, Cornelis

Volltext

A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI von Claassens, Daniel M F, Vos, Gerrit J A, Bergmeijer, Thomas O, Hermanides, Renicus S, van 't Hof, Arnoud W J, van der Harst, Pim, Barbato, Emanuele, Morisco, Carmine, Tjon Joe Gin, Richard M, Asselbergs, Folkert W, Mosterd, Arend, Herrman, Jean-Paul R, Dewilde, Willem J M, Janssen, Paul W A, Kelder, Johannes C, Postma, Maarten J, de Boer, Anthonius, Boersma, Cornelis, Deneer, Vera H M, Ten Berg, Jurriën M

Volltext

Abstract 16390: Cost-effectiveness of a CYP2C19 Genotype-guided Antiplatelet Strategy in ST-elevation Myocardial Infarction Patients von Claassens, Danny M, Vos, Gerrit J, Boersma, Cornelis, Bergmeijer, Thomas, Hermanides, Rik, van t Hof, Arnoud, Van Der Harst, Pim, Barbato, Emanuele, Morisco, Carmine, Tjon Joe Gin, Richard M, Asselbergs, Folkert W, Mosterd, Arend, Herrman, Jean-Paul, Dewilde, Willem, Postma, Maarten J, Deneer, Vera H, ten berg, jurrien m

Volltext

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI von Claassens, Daniel M F, Vos, Gerrit J A, Bergmeijer, Thomas O, Hermanides, Renicus S, van 't Hof, Arnoud W J, van der Harst, Pim, Barbato, Emanuele, Morisco, Carmine, Tjon Joe Gin, Richard M, Asselbergs, Folkert W, Mosterd, Arend, Herrman, Jean-Paul R, Dewilde, Willem J M, Janssen, Paul W A, Kelder, Johannes C, Postma, Maarten J, de Boer, Anthonius, Boersma, Cornelis, Deneer, Vera H M, Ten Berg, Jurriën M

Volltext

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial von Claassens, Daniel M.F, van Dorst, Pim W.M, Vos, Gerrit J.A, Bergmeijer, Thomas O, Hermanides, Renicus S, van ’t Hof, Arnoud W.J, van der Harst, Pim, Barbato, Emanuele, Morisco, Carmine, Tjon Joe Gin, Richard M, Asselbergs, Folkert W, Mosterd, Arend, Herrman, Jean Paul R, Dewilde, Willem J.M, Postma, Maarten J, Deneer, Vera H.M, ten Berg, Jurriën M, Boersma, Cornelis

Volltext